Viavi Solutions (VIAV)

• Market cap: $2.14B
• 1 day: -1.93%
• 5 days: -4.26%
• 1 month: -16.78%
• 3 months: -7.11%
• 6 months: 3.87%
• Year to date: -4.26%
• 1 year: 21.64%
• 5 years: -14.27%
• 10 years: -27.57%
• Sector: Technology
• Industry: Communication Equipment

About: Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.

Employees: 3,600

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

2,546% more call options, than puts

Call options by funds: $4.68M | Put options by funds: $177K

16% more capital invested

Capital invested by funds: $1.88B [Q3] → $2.17B (+$297M) [Q4]

14% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 92

2.68% more ownership

Funds ownership: 93.73% [Q3] → 96.41% (+2.68%) [Q4]

10% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 42

1% more funds holding

Funds holding: 307 [Q3] → 309 (+2) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $8 17% downside
• Avg. target: $12.94 34% upside
• High target: $16 65% upside

8 analyst ratings

• positive: 5 63%
• neutral: 2 25%
• negative: 1 13%

Morgan Stanley Meta Marshall 47% 1-year accuracy 14 / 30 met price target	17% downside $8	Underweight Maintained	8 Apr 2025
Rosenblatt Mike Genovese 28% 1-year accuracy 11 / 40 met price target	45% upside $14	Buy Upgraded	7 Mar 2025
Argus Research Jim Kelleher 8% 1-year accuracy 1 / 12 met price target	65% upside $16	Buy Maintained	5 Feb 2025
UBS Andrew Spinola 0 / 0 met price target	19% upside $11.50	Neutral Maintained	31 Jan 2025
B. Riley Securities Dave Kang 30% 1-year accuracy 3 / 10 met price target	24% upside $12	Neutral Maintained	31 Jan 2025